Medicare Part D coverage · amphotericin B liposomal · RxCUI 967388
amphotericin B liposomal 50 MG Injection [AmBisome]
Per the CMS 2026 Part D formulary file, amphotericin B liposomal 50 MG Injection [AmBisome] is covered by 234 Medicare Part D plans (4.6% of enrollable products), averaging Tier 4.3, with prior authorization required on 81.8% of covering formularies.
- 4.6%
- Plan coverage
- 234
- Plans covering
- T4.3
- Avg tier
- 81.8%
- Prior auth required
What the CMS Formulary Data Shows for amphotericin B liposomal 50 MG Injection [AmBisome]
Per the CMS 2026 Part D formulary file, amphotericin B liposomal 50 MG Injection [AmBisome] (RxNorm concept RXCUI 967388, generic name amphotericin B liposomal) appears on 11 distinct formulary files spanning 234 Medicare Part D plan offerings - 4.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.3.
Real-world access to amphotericin B liposomal 50 MG Injection [AmBisome] depends on utilization management as much as tier placement: 81.8% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 144 Part D beneficiaries filled amphotericin B liposomal 50 MG Injection [AmBisome] in 2023, with total plan-and-beneficiary spending of $1,411,630 and an average per-beneficiary annual cost of $9,802.99. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry amphotericin B liposomal 50 MG Injection [AmBisome] today.
Coverage Details
- Formularies covering
- 11
- Plans covering
- 234
- Coverage rate
- 4.6%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 81.8% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 144
- Total spending
- $1,411,630
- Avg per beneficiary
- $9,802.99
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering amphotericin B liposomal 50 MG Injection [AmBisome]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is amphotericin B liposomal 50 MG Injection [AmBisome] covered by Medicare Part D?
Yes, amphotericin B liposomal 50 MG Injection [AmBisome] is covered by 234 Medicare Part D plans (4.6% of all Part D formularies).
What tier is amphotericin B liposomal 50 MG Injection [AmBisome] on Medicare Part D plans?
amphotericin B liposomal 50 MG Injection [AmBisome] averages Tier 4.3 across Part D plans, ranging from Tier 1 to Tier 5.
Does amphotericin B liposomal 50 MG Injection [AmBisome] require prior authorization?
81.8% of Part D formularies require prior authorization for amphotericin B liposomal 50 MG Injection [AmBisome]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on amphotericin B liposomal 50 MG Injection [AmBisome]?
In 2023, total Medicare Part D spending on amphotericin B liposomal 50 MG Injection [AmBisome] was $1,411,630, covering 144 beneficiaries. The average spend per beneficiary was $9,802.99.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- sapropterin dihydrochloride 100 MG Powder for Oral Solution T4.3
- C1 esterase inhibitor (human) 2000 UNT Injection [Haegarda] T4.3
- tolvaptan 15 MG Oral Tablet T4.3
- perampanel 0.5 MG/ML Oral Suspension [FYCOMPA] T4.3
- pirfenidone 534 MG Oral Tablet T4.3
- 0.5 ML ustekinumab 90 MG/ML Prefilled Syringe [Stelara] T4.3
Similar prior-authorization rate
- tretinoin 0.001 MG/MG Topical Gel 81.8% PA
- nitisinone 2 MG Oral Tablet [Harliku] 81.8% PA
- Twice-Daily diclofenac epolamine 0.013 MG/MG Medicated Patch 81.7% PA
- vorinostat 100 MG Oral Capsule [Zolinza] 81.4% PA
- ondansetron 4 MG Oral Tablet 82.3% PA
- ondansetron 8 MG Oral Tablet 82.3% PA